Persistency of Adenoviral-Mediated Lysostaphin Expression in Goat Mammary Glands

• Published in: Journal of dairy science 2004-03, Vol.87 (3), p.602-608
• Main Authors: Fan, W., Plaut, K., Bramley, A.J., Barlow, J.W., Mischler, S.A., Kerr, D.E.
• Format: Article
• Language: English
• Subjects: Adenoviridae - genetics; Adenoviridae - immunology; adenovirus; Animal productions; Animals; Antibodies, Viral - blood; antibody; Biological and medical sciences; DNA, Recombinant - genetics; Endopeptidases - analysis; Endopeptidases - genetics; Endopeptidases - immunology; Female; Fundamental and applied biological sciences. Psychology; Gene Expression; Genetic Vectors; Goats; Immunoglobulin G - blood; lysostaphin; Mammary Glands, Animal - enzymology; Mammary Glands, Animal - secretion; mastitis; Terrestrial animal productions; Transfection; Vertebrates
• ISSN: 0022-0302; 1525-3198
• DOI: 10.3168/jds.S0022-0302(04)73202-6

Gene therapy has great potential to enable synthesis of protein molecules in targeted cells of an animal. One application may be the production of antibacterial enzymes by the mammary gland as a means of preventing or treating mastitis. We have previously demonstrated that goat mammary cells are capable of producing lysostaphin, an antistaphylococcal enzyme, after being transduced in vivo with a recombinant adenoviral vector containing a modified lysostaphin gene (Ad-lys). The current study examined duration of expression, and antibody response to lysostaphin and the adenoviral vector. Following intramammary infusion into nonlactating goats (n = 4), recovery of transducible adenoviral vector in mammary secretions persisted for 11 d. Transducible vector was not detected in serum, saliva, urine, or feces. Peak lysostaphin concentrations (< 20μg/mL) in mammary secretions of infused udders were detected approximately 1 wk postinfusion, and generally returned to undetectable levels after an additional 1 to 2 wk. The poor persistency of expression was likely due to the very potent immune response to both the adenovirus and the expressed lysostaphin. Serum IgG antibodies recognizing the adenoviral vector developed within 7 d of the infusion, and titers rose dramatically to greater than 1:1×105. Similar titers of serum IgG antibodies to lysostaphin developed in 3 goats, with more moderate titers in the fourth goat. The antibody response to lysostaphin was delayed by approximately 4 d in comparison to the response to the adenovirus. Serum IgG antibody profiles were reflected in mammary secretions. No IgA antibodies to adenovirus or lysostaphin were detected in sera or mammary secretion. We demonstrate that while the lysostaphin gene can be introduced to the mammary gland using an adenoviral-mediated gene transfer technique, the strong immune response that it provokes makes the approach unsuitable for combating mastitis.